Your body’s metabolism is like a high-performance engine. Over time, it builds up cellular waste or "junk". For decades, researchers sought a biological switch to trigger autophagy. This is a vital self-cleaning mode for cells. Rapamycin is the most promising switch discovered so far. It was originally found in the soil of Easter Island. The…

Recent clinical research highlights a distinction in rapamycin dosing. Chronic high doses can blunt acute protein synthesis. However, intermittent dosing for longevity does not necessarily prevent muscle growth. This is especially true when paired with consistent resistance training. Individuals should understand the nuance between acute inhibition and long-term adaptation. This knowledge allows them to balance…

The landscape of chronic illness treatment is shifting as researchers move beyond mere symptom management toward addressing the biological roots of exhaustion. As we move through 2026, a clear trend has emerged: rapamycin, once known primarily as a transplant drug and longevity "miracle," is being repurposed as a precision tool for patients battling Long COVID…

Rapamycin is the strongest drug candidate in longevity research so far, but it is not yet a proven “true anti-aging drug” in humans. The evidence is compelling in animals and promising in early human studies, yet we still lack the kind of large, long-term trials needed to say it reliably slows human aging. Rapamycin sits…

People are tracking the latest breakthroughs in clinical longevity, already know that rapamycin has shifted from a niche immunosuppressant to the most heavily debated molecule in geroscience. But exactly why would a doctor prescribe rapamycin today? For decades, the FDA has approved rapamycin (known generically as sirolimus) specifically to prevent organ transplant rejection and treat…